Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.
- DOI
- 10.1530/etj-23-0047
- Published
- 2023 Jul 1
- Container
- European thyroid journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1530/etj-23-0047,
title = {Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.},
author = {Colombo C and Ceruti D and De Leo S and Bilo G and Trevisan M and Giancola N and Moneta C and Parati G and Persani L and Fugazzola L},
year = {2023},
journal = {European thyroid journal},
doi = {10.1530/etj-23-0047},
url = {https://doi.org/10.1530/etj-23-0047}
}RIS
TY - JOUR TI - Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm. AU - Colombo C AU - Ceruti D AU - De Leo S AU - Bilo G AU - Trevisan M AU - Giancola N AU - Moneta C AU - Parati G AU - Persani L AU - Fugazzola L PY - 2023 JO - European thyroid journal DO - 10.1530/etj-23-0047 UR - https://doi.org/10.1530/etj-23-0047 ER -
APA
C, C., D, C., S, D. L., G, B., M, T., N, G., C, M., G, P., L, P., & L, F. (2023). Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm.. European thyroid journal. https://doi.org/10.1530/etj-23-0047
Source records
- pubmed · retrieved 2026-11-10T10:42:05.043Z